Remarkably, the EZH2–E2F1 complex was found to mechanistically modulate chromatin accessibility, thereby promoting cancer cell proliferation while inhibiting G2/M phase arrest and apoptosis in TNBC (Fig. 3). This evidence concerns the gene E2F1 and cancer.